Aveanna Healthcare Holdings Inc. (AVAH) shares surged 9.96% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results and an upward revision of its full-year guidance.
The home healthcare provider reported Q1 revenue of $559.2 million, significantly surpassing the analyst consensus estimate of $513.1 million. This represents a robust 14% increase compared to the same period last year. The company's adjusted EBITDA also outperformed expectations, coming in at $67.4 million versus the forecasted $39.9 million.
Adding to the positive sentiment, Aveanna raised its full-year 2025 outlook. The company now projects revenue to exceed $2.15 billion, up from its previous guidance range of $2.10 - $2.12 billion. Additionally, the adjusted EBITDA forecast was increased to over $207 million, a substantial improvement from the earlier projected range of $190 - $194 million. This upward revision in guidance signals management's confidence in the company's growth trajectory and operational efficiency.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.